IP Library › Granted Patent US 12,571,732
Granted Patent B2
US 12,571,732 · App. 17/360,477 · Granted Mar 10, 2026

Methods and systems for point-of-care coagulation assays by optical detection

Inventors: Josef Kerimo (Concord, MA); Hansong Zeng (Acton, MA); Ron Scharlack (Brookline, MA); Gert Blankenstein (Cambridge, MA)
Assignee: Instrumentation Laboratory Company
G01N21/534G01N21/59G01N21/6408G01N21/6486G01N21/65G01N33/4905G01N2201/062G01N2201/0636
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,571,732
App. No.
17/360,477
Granted
Mar 10, 2026
Kind
B2
Abstract

An assay system includes an excitation light source to output excitation light having a first wavelength; an optical reference positioned to absorb the excitation light from the excitation light source and to output an optical signal based on the excitation light, where the optical signal has a second wavelength that is different from the first wavelength; a reaction chamber containing a reactant and an inlet to receive a test sample to produce a fluid that is based on the test sample and the reactant, where the reaction chamber is positioned to receive the optical signal from the optical reference; and an optical receiver positioned to detect an amount of the optical signal that passed through the reaction chamber containing the fluid.

Claims (23)

1 . An assay system comprising:

an excitation light source to output excitation light having a first wavelength;

an optical reference positioned to absorb the excitation light from the excitation light source and to output an optical signal based on the excitation light, the optical signal having a second wavelength that is different from the first wavelength;

a reaction chamber comprising a reactant and an inlet to receive a test sample to produce a fluid that is based on the test sample and the reactant, the reaction chamber being positioned to receive the optical signal from the optical reference;

an optical receiver positioned to detect an amount of the optical signal that passed through the reaction chamber containing the fluid;

wherein the optical reference is positioned between the excitation light source and the reaction chamber, and wherein the reaction chamber is positioned between the optical reference and the optical receiver; and

a test instrument to detect an analyte or coagulation associated with the test sample based on the amount of the optical signal that passed through the reaction chamber containing the fluid.

2 . The assay system of claim 1 , wherein the reaction chamber holds the test sample in the absence of a colorimetric reagent.

3 . The assay system of claim 1 , wherein the first wavelength ranges from 20 nm (nanometers) to 5000 nm.

4 . The assay system of claim 1 , wherein the optical reference is selected from the group consisting of fluorescence doped glass, stained glass, dyed glass, materials showing Raman effect, fluorescent polymer film, and fluorescent polymer sheet.

5 . The assay system of claim 1 , wherein the reaction chamber comprises a lumen, a planar first wall, and a planar second wall that is opposite and parallel to the planar first wall.

6 . The assay system of claim 5 , wherein the planar first wall and the planar second wall are each optically transparent to light in a wavelength range of about 20 nm (nanometers) to about 5000 nm.

7 . The assay system of claim 6 , wherein the first wavelength is in a range of about 20 nm to about 2000 nm.

8 . The assay system of claim 5 , wherein each of the planar first and second walls of the reaction chamber comprises a luminal surface, and wherein a luminal surface is coated with the reactant.

9 . The assay system of claim 1 , wherein the optical receiver and the excitation light source are integrated.

10 . The assay system of claim 1 , wherein the optical receiver comprises a light detector.

11 . The assay system of claim 1 , wherein the reaction chamber further comprises a reaction fluid outlet port.

12 . The assay system of claim 1 , wherein the inlet is V-shaped.

13 . The assay system of claim 1 , wherein the optical receiver comprises a light detector for detecting the amount of the optical signal that passed through the reaction chamber containing the fluid.

14 . The assay system of claim 1 , wherein the optical signal is a fluorescence signal.

15 . The assay system of claim 1 , wherein the reaction chamber comprises more than one reactant.

16 . The assay system of claim 1 , wherein the reactant comprises a reagent.

17 . The assay system of claim 16 , wherein the reagent is a dry reagent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2026
From: KERIMO, JOSEF; ZENG, HANSONG; SCHARLACK, RON; BLANKENSTEIN, GERT
To: INSTRUMENTATION LABORATORY COMPANY
Reel/Frame 073682/0170 →
Continuity (3)
Continuation 14696756 · Apr 27, 2015
Provisional Application 61986475 · Apr 30, 2014
Related Publication 20220018765A1 · Jan 20, 2022
References Cited (50)
US 4964728A · Kloth et al. · 1990 [cited by applicant]
US 5114860A · Hayashi · 1992 [cited by applicant]
US 5525466A · Slovacek et al. · 1996 [cited by applicant]
US 6252664B1 · Barbera-Guillem · 2001 [cited by applicant]
US 6352630B1 · Frenkel et al. · 2002 [cited by applicant]
US 8558205B2 · Ikari et al. · 2013 [cited by applicant]
US 9500589B2 · Nakatani et al. · 2016 [cited by applicant]
US 11079325B2 · Kerimo · 2021 [cited by examiner]
US 20020064800A1 · Sando et al. · 2002 [cited by applicant]
US 20030180191A1 · Suzuki et al. · 2003 [cited by applicant]
US 20050101025A1 · Ho · 2005 [cited by applicant]
US 20060178570A1 · Robinson et al. · 2006 [cited by applicant]
US 20070212793A1 · Dejneka · 2007 [cited by examiner]
US 20080096285A1 · Koyata et al. · 2008 [cited by applicant]
US 20130301051A1 · Pogosyan et al. · 2013 [cited by applicant]
US 20140004527A1 · Oka et al. · 2014 [cited by applicant]
US 20160341665A1 · Nagatomi · 2016 [cited by examiner]
CN 101194309A · 2008 [cited by applicant]
CN 101677766A · 2010 [cited by applicant]
CN 101821610A · 2010 [cited by applicant]
CN 104897599A · 2015 [cited by applicant]
EP 1496351A2 · 2005 [cited by applicant]
EP 3104167A1 · 2016 [cited by applicant]
JP 2002345787A · 2002 [cited by applicant]
JP 2010101835A · 2010 [cited by applicant]
JP 2011048677A · 2011 [cited by applicant]
WO 0058715A2 · 2000 [cited by applicant]
WO 2000058715A2 · 2000 [cited by applicant]
WO 2011001681A1 · 2011 [cited by applicant]
WO 2012096566A1 · 2012 [cited by applicant]
WO 2012137506A1 · 2012 [cited by applicant]
WO 2013161543A1 · 2013 [cited by applicant]
WO 2015118843A1 · 2015 [cited by applicant]
Communication pursuant to Article 94(3) EPC for European Patent Application No. 15720890.1, issued Feb. 7, 2023, (6 pages). [cited by applicant]
Office Action received for European Patent Application No. 15720890.1, mailed on Feb. 19, 2025, 5 pages. [cited by applicant]
Canadian Intellectual Property Office, Office Action, Canadian Application No. 2,946,877, 7 pages. [cited by applicant]
Examination Report from related Australian Application No. 2015253478, issued Jul. 27, 2018. [cited by applicant]
Examination Report No. 1, Australian Patent Application No. 2015253478, dated Nov. 16, 2017, 3 pages. [cited by applicant]
First Office Action from related Chinese Application No. 201580034415.3, issued Jul. 31, 2018, includes English translation. [cited by applicant]
Hemker et al., “Calibrated Automated Thrombin Generation Measurement in Clotting Plasma,” Pathophysiology of Haemostatis and Thrombosis, 33, Apr. 15, 2003. [cited by applicant]
Canadian Office Action, Canadian Patent Application No. 2,946,877, dated Apr. 10, 2019, 5 pages. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2015/027715, dated Nov. 10, 2016 (10 pages). [cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US2015/027715, mailed on Jul. 22, 2015, 14 pages. [cited by applicant]
Final Notice of Reasons for Rejection for Japanese Patent Application No. 2019-140602, issued May 31, 2021, with English Translation (7 pages). [cited by applicant]
Japanese Office Action, Japanese Patent Application No. 2017-564011, dated Nov. 28, 2018, 3 pages (Translation Included, 4 pages). [cited by applicant]
Office Action dated Oct. 28, 2020, issued in corresponding Japanese Application No. 2019-140602, 3 pages and English Translation thereof, 4 pages. [cited by applicant]
Decision to Grant received for Japanese Patent Application No. 2016-564011, mailed on Jul. 2, 2019, 5 pages (2 pages of English Translation and 3 pages of Original Document). [cited by applicant]
Office Action received for Japanese Patent Application No. 2019-140602, mailed on Dec. 20, 2021, 2 pages (1 page of English Translation and 1 page of Original Document). [cited by applicant]
Office Action received for European Patent Application No. 15 720 890.1-1001, mailed Oct. 23, 2025, 5 pages. [cited by applicant]
Office Action received for Japanese Patent Application No. 2016-564011, mailed on Nov. 28, 2018, 6 pages (3 pages of English Translation and 3 pages of Original Document). [cited by applicant]